Alucent Vessel Restoration System for AVF — Activate AVF

AV Fistula Clinical Trial

Official title:
A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of Upper-extremity Autologous End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease: ACTIVATE AVF

Status Recruiting

Clinical Trial Summary

Feasibility of the Vessel Restoration System for AVF

Clinical Trial Description

A study of the safety and feasibility of the Vessel Restoration System for AVF to promote the physiologic and functional maturation of a Brachiocephalic End-to-Side Arteriovenous Fistulas (AVF) in Patients with Chronic Kidney Disease Stage V (Pre-dialysis): ACTIVATE AVF ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05462223
Study type	Interventional
Source	Alucent Biomedical
Contact	Kate Ecklund, MPH
Phone	3857722300
Email	kecklund@alucentbiomedical.com
Status	Recruiting
Phase	N/A
Start date	July 15, 2022
Completion date	December 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02363972` - Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD	N/A
Terminated	`NCT04626427` - The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation	N/A
Completed	`NCT01471041` - Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae	Phase 2/Phase 3
Not yet recruiting	`NCT05569109` - av Fistula Patency Loss as a Cause of Fistula Failure and Hyperphosphatemia
Completed	`NCT02475837` - Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access	Phase 2
Active, not recruiting	`NCT04484220` - Ellipsys Vascular Access System Post Market Surveillance (PS) Study	N/A
Active, not recruiting	`NCT04327609` - SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications	N/A